NeoGenomics, Inc. is an operator of a network of cancer-focused genetic testing laboratories. The Company operates in Laboratory Testing Segment. Its Laboratory Testing segment delivers testing services to hospitals, pathologists, oncologists, other clinicians and researchers. The Company offers testing services, which includes Cytogenetics testing, which is the study of normal and abnormal chromosomes and their relationship to disease; fluorescence in-situ hybridization (FISH) testing, which is a branch of cancer genetics that focuses on detecting and locating the presence or absence of specific deoxyribonucleic acid (DNA) sequences and genes on chromosomes; flow cytometry testing, which is a way to measure the characteristics of cell populations, and immunohistochemistry (IHC), and digital imaging, which is a process of localizing proteins in cells of a tissue section and relies on the principle of antibodies binding specifically to antigens in biological tissues.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Laboratories & Research
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: NEO
- Previous Close: $7.90
- 50 Day Moving Average: $8.34
- 200 Day Moving Average: $8.38
- 52-Week Range: $5.90 - $9.88
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 25.09
- P/E Growth: 2.91
- Market Cap: $643.01M
- Outstanding Shares: 78,512,000
- Beta: 0.92
- Net Margins: -3.10%
- Return on Equity: 3.56%
- Return on Assets: 2.05%
Companies Related to NeoGenomics:
- Debt-to-Equity Ratio: 0.29%
- Current Ratio: 2.62%
- Quick Ratio: 2.45%
What is NeoGenomics' stock symbol?
NeoGenomics trades on the NASDAQ under the ticker symbol "NEO."
Where is NeoGenomics' stock going? Where will NeoGenomics' stock price be in 2017?
8 equities research analysts have issued 12-month price objectives for NeoGenomics' stock. Their predictions range from $10.00 to $12.00. On average, they anticipate NeoGenomics' stock price to reach $10.67 in the next year.
When will NeoGenomics announce their earnings?
NeoGenomics is scheduled to release their next quarterly earnings announcement on Monday, February, 27th 2017.
Who owns NeoGenomics stock?
NeoGenomics' stock is owned by many different of institutional and retail investors. Top institutional shareholders include Artisan Partners Limited Partnership (3.28%), First Light Asset Management LLC (3.28%), Russell Investments Group Ltd. (1.94%), Cortina Asset Management LLC (1.56%), Castleark Management LLC (1.24%) and State Street Corp (1.17%). Company insiders that own NeoGenomics stock include Alison L Hannah, Bruce K Crowther, George Cardoza, Lynn A Tetrault, Maher Albitar, Oort Douglas M Van, Robert J Shovlin, Steven A Ross and Steven C Jones.
Who sold NeoGenomics stock? Who is selling NeoGenomics stock?
NeoGenomics' stock was sold by a variety of institutional investors in the last quarter, including Allianz Asset Management AG, Artisan Partners Limited Partnership, Nicholas Investment Partners LP, Royce & Associates LP, Kopp Investment Advisors LLC, Terril Brothers Inc., Bard Associates Inc. and AQR Capital Management LLC. Company insiders that have sold NeoGenomics stock in the last year include George Cardoza, Maher Albitar, Oort Douglas M Van, Steven A Ross and Steven C Jones.
Who bought NeoGenomics stock? Who is buying NeoGenomics stock?
NeoGenomics' stock was purchased by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., First Light Asset Management LLC, William Blair Investment Management LLC, Cortina Asset Management LLC, Millrace Asset Group Inc., Dimensional Fund Advisors LP, Axiom International Investors LLC DE and Century Capital Management LLC. Company insiders that have bought NeoGenomics stock in the last two years include Alison L Hannah, Bruce K Crowther, Lynn A Tetrault and Robert J Shovlin.
How do I buy NeoGenomics stock?
Shares of NeoGenomics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of NeoGenomics stock cost?
One share of NeoGenomics stock can currently be purchased for approximately $8.03.